| Variable . | Study population (N = 25 144) . |
|---|---|
| Demographics | |
| Race/ethnicity, n (%) | |
| White non-Hispanic | 22 983 (91.4%) |
| White Hispanic | 805 (3.2%) |
| Black or African American | 699 (2.8%) |
| Other | 657 (2.6%) |
| Female sex, n (%) | 13 548 (54%) |
| Chronological age, years | 53.71 ± 11.59 |
| AI ECG age, years | 54.59 ± 10.99 |
| Age-Gap, years | 0.88 ± 7.41 |
| Clinical history | |
| Body mass index | 28.71 ± 6.30 |
| Heart failure history, n (%) | 2371 (9%) |
| COPD history, n (%) | 1334 (5%) |
| Chronic kidney disease history, n (%) | 1209 (5%) |
| Current smoker, n (%) | 3969 (16%) |
| Diabetes history n (%) | 2551 (10%) |
| Hypertension history, n (%) | 4215 (17%) |
| Dyslipidaemia history, n (%) | 5438 (22%) |
| Alcoholism history, n (%) | 1267 (5%) |
| Variable . | Study population (N = 25 144) . |
|---|---|
| Demographics | |
| Race/ethnicity, n (%) | |
| White non-Hispanic | 22 983 (91.4%) |
| White Hispanic | 805 (3.2%) |
| Black or African American | 699 (2.8%) |
| Other | 657 (2.6%) |
| Female sex, n (%) | 13 548 (54%) |
| Chronological age, years | 53.71 ± 11.59 |
| AI ECG age, years | 54.59 ± 10.99 |
| Age-Gap, years | 0.88 ± 7.41 |
| Clinical history | |
| Body mass index | 28.71 ± 6.30 |
| Heart failure history, n (%) | 2371 (9%) |
| COPD history, n (%) | 1334 (5%) |
| Chronic kidney disease history, n (%) | 1209 (5%) |
| Current smoker, n (%) | 3969 (16%) |
| Diabetes history n (%) | 2551 (10%) |
| Hypertension history, n (%) | 4215 (17%) |
| Dyslipidaemia history, n (%) | 5438 (22%) |
| Alcoholism history, n (%) | 1267 (5%) |
Data are n (%) or mean (SD).
AI ECG Age, artificial intelligence enabled ECG age; Age-Gap, AI ECG age minus chronological age.
| Variable . | Study population (N = 25 144) . |
|---|---|
| Demographics | |
| Race/ethnicity, n (%) | |
| White non-Hispanic | 22 983 (91.4%) |
| White Hispanic | 805 (3.2%) |
| Black or African American | 699 (2.8%) |
| Other | 657 (2.6%) |
| Female sex, n (%) | 13 548 (54%) |
| Chronological age, years | 53.71 ± 11.59 |
| AI ECG age, years | 54.59 ± 10.99 |
| Age-Gap, years | 0.88 ± 7.41 |
| Clinical history | |
| Body mass index | 28.71 ± 6.30 |
| Heart failure history, n (%) | 2371 (9%) |
| COPD history, n (%) | 1334 (5%) |
| Chronic kidney disease history, n (%) | 1209 (5%) |
| Current smoker, n (%) | 3969 (16%) |
| Diabetes history n (%) | 2551 (10%) |
| Hypertension history, n (%) | 4215 (17%) |
| Dyslipidaemia history, n (%) | 5438 (22%) |
| Alcoholism history, n (%) | 1267 (5%) |
| Variable . | Study population (N = 25 144) . |
|---|---|
| Demographics | |
| Race/ethnicity, n (%) | |
| White non-Hispanic | 22 983 (91.4%) |
| White Hispanic | 805 (3.2%) |
| Black or African American | 699 (2.8%) |
| Other | 657 (2.6%) |
| Female sex, n (%) | 13 548 (54%) |
| Chronological age, years | 53.71 ± 11.59 |
| AI ECG age, years | 54.59 ± 10.99 |
| Age-Gap, years | 0.88 ± 7.41 |
| Clinical history | |
| Body mass index | 28.71 ± 6.30 |
| Heart failure history, n (%) | 2371 (9%) |
| COPD history, n (%) | 1334 (5%) |
| Chronic kidney disease history, n (%) | 1209 (5%) |
| Current smoker, n (%) | 3969 (16%) |
| Diabetes history n (%) | 2551 (10%) |
| Hypertension history, n (%) | 4215 (17%) |
| Dyslipidaemia history, n (%) | 5438 (22%) |
| Alcoholism history, n (%) | 1267 (5%) |
Data are n (%) or mean (SD).
AI ECG Age, artificial intelligence enabled ECG age; Age-Gap, AI ECG age minus chronological age.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
